What does Helix BioMedix, Inc. do?

Helix BioMedix, Inc. (HXBM) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is HXBM's market cap?

Helix BioMedix, Inc. (HXBM) has a market capitalization of approximately $393,239, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does HXBM pay a dividend?

No — Helix BioMedix, Inc. (HXBM) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Helix BioMedix, Inc. (HXBM) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

HXBM

Helix BioMedix, Inc.

OTC·Biotechnology · Healthcare

$1.75$0.00+0.00%

After hours·$1.75+0.00%

Market cap$393.24K·Market closed·Aug 26 8:00 PM UTC

Price Chart

$1.75+$0.00 (+0.00%)today

−92.94%CAGR −41.16%

Select date range

FromTo

Mar 25, 1999Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

HXBM does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateNov 9

Last Report DateNov 9

Reported vs Estimate−$6.06

Earnings Surprise—

Income Statement Flow

PRO

See exactly how HXBM's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for HXBM and 80,000+ other tickers.

About Helix BioMedix, Inc.

Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company was founded in 1988 and is headquartered in Bothell, WA.

CEO: Robin L. Carmichael
Sector: Healthcare
Industry: Biotechnology
Exchange: OTC
Employees: 8
Website: www.helixbiomedix.com

Peers

Bio-Path Holdings, Inc.

Cap

$280.3K

EMMA

Emmaus Life Sciences, Inc.

Cap

$3.0M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About HXBM

What does Helix BioMedix, Inc. do?: Helix BioMedix, Inc. (HXBM) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is HXBM's market cap?: Helix BioMedix, Inc. (HXBM) has a market capitalization of approximately $393,239, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does HXBM pay a dividend?: No — Helix BioMedix, Inc. (HXBM) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is HXBM profitable?: Helix BioMedix, Inc. (HXBM) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.